Alicia V. Palleroni

Rational Design of a Potent, Long-Lasting Form of Interferon:  A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C

Pascal Bailon, Alicia V. Palleroni, Carol Ann Schaffer et al. · Bioconjugate Chemistry · 2001 · 609 citations

Interferon Alpha-2a, Translational Medicine, Ethylene Glycol +15

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

Loretta M. Itri, Marilyn Campion, Robert A. Dennin et al. · Cancer · 1987 · 119 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +21

Positional Isomers of Monopegylated Interferon α-2a: Isolation, Characterization, and Biological Activity

Seth P. Monkarsh, Yuemei Ma, Anthony Aglione et al. · Analytical Biochemistry · 1997 · 113 citations

Biological Activity, Bioorganic Chemistry, Biochemistry +5

Relationship between binding affinities to cellular retinoic acid-binding protein and in vivo and in vitro properties for 18 retinoids.

Patrick W. Trown, Alicia V. Palleroni, Oksana Bohoslawec et al. · PubMed · 1980 · 76 citations

Cell Proliferation, Vitro Properties, Cellular Physiology +18

Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.

Figlin Ra, J B deKernion, Eliahu Mukamel et al. · Journal of Clinical Oncology · 1988 · 71 citations

Antitumor Activity, Anti-interferon Antibody Formation, Immunology +16